Ritonavir-boosted ARV linked to adrenal dysfunction in babies

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2011年 / 1360卷 / 1期
关键词：
Zidovudine; Ritonavir; Congenital Adrenal Hyperplasia; Lopinavir; 17OHP Level;
D O I：
10.2165/00128415-201113600-00001
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 1
相关论文
共 50 条
  • [41] Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals
    Dickinson, Laura
    Boffito, Marta
    Back, David J.
    Khoo, Saye H.
    Pozniak, Anton L.
    Mugyenyi, Peter
    Merry, Concepta
    Autar, Reshma Saskia
    Burger, David M.
    Aarons, Leon J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1344 - 1355
  • [42] Effect of ritonavir-boosted tipranavir or darunavir on the steady-state pharmacokinetics of elvitegravir
    Mathias, Anita A.
    Hinkle, John
    Shen, Gong
    Enejosa, Jeff
    Piliero, Peter J.
    Sekar, Vanitha
    Mack, Rebecca
    Tomaka, Frank
    Kearney, Brian P.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 49 (02) : 156 - 162
  • [43] Use of Apixaban in Atrial Fibrillation With Ritonavir-Boosted Antiretroviral Therapy: A Case Report
    Lomakina, Veronica
    Sozio, Stephen J.
    Tekle, Jowana
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (03) : 728 - 732
  • [44] Switch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoring
    Rodriguez-Novoa, Sonia
    Morello, Judit
    Barreiro, Pablo
    Maida, Ivana
    Garcia-Gasco, Pilar
    Vispo, Eugenia
    Gonzalez-Pardo, Gema
    Parra, Antonio
    Jimenez-Nacher, Inmaculada
    Soriano, Vincent
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (06) : 821 - 825
  • [45] Pharmacokinetic Interaction Study of Ritonavir-Boosted Saquinavir in Combination with Rifabutin in Healthy Subjects
    Zhang, Xiaoping
    Fettner, Scott
    Zwanziger, Elke
    Rowell, Lucy
    Salgo, Miklos
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (02) : 680 - 687
  • [46] Adrenal Dysfunction in HIV-Exposed Uninfected Infants Receiving Ritonavir-Boosted Lopinavir, an HIV Protease Inhibitor, for the Prevention of Breastfeeding HIV Transmission. An ANRS 12174 Substudy
    Polak, Michel
    Wudy, Stefan
    Meda, Nicolas
    Hartmann, Michaela
    Kankasa, Chipepo
    Tumwine, James
    Laborde, Kathleen
    Hofmeyr, Justus
    Vallo, Roselyne
    Nagot, Nicolas
    Tylleskar, Thorkild
    Van de Perre, Philippe
    Blanche, Stephane
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 72 - 72
  • [47] Drug interactions between boceprevir and certain ritonavir-boosted HIV protease inhibitors
    Reactions Weekly, 2012, 1389 (1) : 2 - 2
  • [48] Pharmacokinetic interactions between ritonavir-boosted darunavir and NNRTIs: A report of 3 cases
    Rawizza, Holly E.
    Sax, Paul E.
    AIDS READER, 2008, 18 (09): : 466 - +
  • [49] Effectiveness of monotherapy with a ritonavir-boosted protease inhibitor for HIV patients in clinical practice
    Moron Romero, Rocio
    Valle, Margarita
    Rodriguez, Alejandro
    Nieto, Pelayo
    Casas, Inmaculada
    Cabeza, Jose
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 330 - 330
  • [50] LACK OF DRUG-DRUG INTERACTION BETWEEN MERICITABINE AND RITONAVIR-BOOSTED DANOPREVIR
    Moreira, S.
    Goelzer, P.
    Weigl, P.
    Badman, E.
    Poirer, A.
    Brennan, B. J.
    Chen, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S22 - S22
12345